We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. What if your doctor could instantly test dozens of different treatments to discover the perfect one for your body, your health and your values? In my lab at Stanford University School of Medicine, we are working on artificial intelligence (AI) technology to create a "digital twin": a virtual representation of you based on your medical history, genetic profile, age, ethnicity, and a host of other factors like whether you smoke and how much you exercise. If you're sick, the AI can test out treatment options on this computerized twin, running through countless different scenarios to predict which interventions will be most effective. Instead of choosing a treatment regimen based on what works for the average person, your doctor can develop a plan based on what works for you.
Two of the most significant predictions for the new decade are that AI will become more pervasive, and the U.S. health-care system will need to evolve. AI can augment and improve the health-care system to serve more patients with fewer doctors. However, health innovators need to be careful to design a system that enhances doctors' capabilities, rather than replace them with technology and also to avoid reproducing human biases. A recent study published in Nature (in collaboration with Google) reports that Google AI detects breast cancer better than human doctors. Babylon Health, the AI-based mobile primary care system implemented in the United Kingdom in 2013, is coming to the U.S. Health-care is an industry in need of AI assistance due to a shortage of doctors and physician burnout.
Research into Artificial Intelligence (AI) has been ongoing for decades, with early proposals dating back to 1950. However, only in recent years, it has seen a resurgence in popularity thanks to the increased availability of computing power and the growth of big data and machine learning. AI is the ability of machines to perform tasks that ordinarily require human intelligence, such as understanding natural language and recognizing objects. With the rapid expansion of AI, there are opportunities for businesses and individuals alike to capitalize on its capabilities. AI is a field of computer science and engineering focused on the creation of intelligent agents, which are systems that can reason, learn, and act autonomously.
When it was first commercialized, the steam engine cost much more than other power sources available – until it didn't. The engine, developed to pump water from flooded mines, allowed for deeper and less costly digging of coal. Then came faster transportation with cheaper shipping of more products and – as accessibility increased with efficiency – more people. The full promise of a breakthrough isn't in what it does initially. It's in what it enables, eventually.
This is the first episode in our series Smarter health. American health care is complex. In the first episode in our series Smarter health, we explore the potential of AI in health care -- from predicting patient risk, to diagnostics, to just helping physicians make better decisions. Today, On Point: We consider whether AI's potential can be realized in our financially-motivated health care system. Welcome to an On Point special series: Smarter health: Artificial intelligence and the future of American health care. In the not so distant future, artificial intelligence and machine learning technologies could transform the health care you receive, whether you're aware of it or not. Here are just a couple of examples. Dr. Vindell Washington is chief clinical officer at Verily Life Sciences, which is owned by Google's parent company, Alphabet. Washington oversees the development of Onduo. Technology that weaves together multiple streams of complex, daily medical data in order to guide and personalize health care decisions across entire patient populations. VINDELL WASHINGTON [Tape]: You might have a blood pressure cuff reading, you may have a blood sugar reading, you may have some logging that you've done.
Vara, the Berlin-based deep tech startup on a mission to provide every woman worldwide with life-saving access to better breast cancer screening, is today announcing a collaboration with researchers from Sweden's world-renowned medical university Karolinska Institutet. The objective of the collaboration is to independently evaluate Vara's AI model for mammography screening, including comparisons with other similar AI systems. Following publication, the results will be used in the creation of a platform to validate AI systems being used in breast imaging, known as the VAI-B Platform (Validation of AI in Breast Imaging). The VAI-B Platform is part of a Swedish-born project financed by Vinnova, Sweden's innovation agency, and Regional Cancer Centers in Collaboration. It is intended to be used as a national and, possibly, international resource for the validation of AI systems in breast imaging.
This article is going to be a snapshot of some things going on in Artificial Intelligence at the intersection of healthcare. Are you an iOS User and like Online surveys? Jasmine Sun asked me to share this opportunity with you guys: Participate in a Substack reader interview. They are looking for Substack users who aren't power users. I most recently covered in the A.I. intersection of Healthcare the following topics: Artificial Intelligence is Taking on Parkinson's Disease.
ANJA KASPERSEN: Today I am very pleased to be joined by Pascale Fung. Pascale is a;rofessor in the Department of Electronic and Computer Engineering and Department of Computer Science and Engineering at The Hong Kong University of Science and Technology. She is known globally for her pioneering work on conversational artificial intelligence (AI), computational linguistics, and was one of the earliest proponents of statistical and machine-learning approaches for natural language processing (NLP). She is now leading groundbreaking research on how to build intelligent systems that can understand and empathize with humans. I have really been looking forward to this conversation with you. Your professional accolades are many, most of which we will touch on during our conversation. However, for our listeners to get to know you a bit better, I would like us to go back to your upbringing during what I understand to be a very tenuous political period in China. I was born, spent my childhood, ...
AI and Robotics are already working in several healthcare establishments. Additionally, in the dermatology sector, AI is detecting skin cancer. The process of detecting skin cancer involves a technology, "MelaFind," that uses infrared light to evaluate the skin condition. Afterward, with its sophisticated algorithms, AI evaluates the scanned data to determine skin cancer's seriousness. AI and Robotics require more unveiling and continued experimentation to become an integral part of the industry and bring innovations through these emerging technologies. The ubiquitous growth of these two technologies has the potential to transform numerous aspects of healthcare.
Now, we trust the complex processes underlying artificial intelligence (AI) with everything from navigation to movie recommendations to targeted advertising. Can we also trust machine learning with our health care? The integration of AI and cancer care was a popular topic in 2021, as evidenced by prominent sessions at two of last year's AACR conferences: the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held virtually October 6-8, 2021, and the San Antonio Breast Cancer Symposium (SABCS), held in a hybrid format December 7-10, 2021. During these sessions, experts gave an overview of how machine learning works, shared data on new applications of AI technologies, and emphasized important considerations for making algorithms equitable. Recognizing that a diverse audience of breast cancer clinicians and researchers may have questions about the fundamentals of AI, the SABCS session "Artificial Intelligence: Beyond the Soundbites" opened with a talk titled, "Everything You Always Wanted to Know About AI But Were Afraid to Ask," presented by Regina Barzilay, PhD, the AI faculty lead at the Jameel Clinic of the Massachusetts Institute of Technology.